Stockreport

BRIEF-Hemispherx Provides An Update To Stockholders Highlighting Cancer Focus [Reuters]

HEMISPHERX BIOPHARMA  (HEB) 
NASDAQ:AMEX Investor Relations: hemispherx.net/mobile/investor-relations.php
PDF BRIEF-Hemispherx Provides An Update To Stockholders Highlighting Cancer Focus | Reuters Reuters Staff 1 Min Read May 2 (Reuters) - Hemispherx Biopharma Inc: * HEMISPHERX [Read more]